Medtech firm Heartflow was valued at $2.27 billion on Friday, with its shares surging 47.4% in the Nasdaq debut, as the IPO ...

HeartFlow’s AI-based CAD platform targets a large market with strong adoption, but IPO valuation and risks warrant caution.

Medical technology company Heartflow said on Wednesday it was targeting a valuation of up to $1.46 billion in its upsized ...

An array of health-related updates includes the resolution of the U.S. saline shortage by the FDA, predictions about a missed ...

Heartflow (NASDAQ: HTFL) stock surges ~50% as the company focused on AI-driven tools for the diagnosis of heart diseases make ...

HeartFlow joins a group of medtechs planning to go public in 2025, including Medtronic’s new standalone diabetes business and ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

It seems there’s fresh blood pumping back into the IPO market. After a blowout initial public offering from Figma last week, ...

Shares of Heartflow are slated to make their trading debut Friday after the coronary-care company's upsized initial public offering was priced above increased expectations.

Heartflow Inc. upped the price of shares in its IPO for a second time to $19 on Aug. 7 before opening on the Nasdaq as “HTFL” ...

Heartflow shares surged 49% after their trading debut, boosting the stock further after its initial public offering was ramped up in recent days. Shares were changing hands at around $28.33 in midday ...

Medical technology company Heartflow said on Friday it was targeting a valuation of up to $1.32 billion in its U.S. initial ...